With a vast offering of development capabilities, global manufacturing and regulatory services, our solutions are comprehensive.
Our clinical packaging facilities in China, Singapore, and Japan together form a regional network ready to support your next clinical study.
Catalent is your partner for over-the-counter formulations. We feature a range of formulations to meet consumer needs in every category.
Queen Mathilde of Belgium visits Catalent Cell and Gene Therapy facilities at Biopark Charleroi on June 21, 2023 in Charleroi, Belgium.
#Catalent is hiring! #Product Manager, Consumer #Health - VMS & Beauty in #Somerset, apply now! #job https://t.co/sZuGBOqkB6
Successful supplement and nutraceutical products are built upon a foundation of nutritional science and the art of dose form design.
Cycle Pharmaceuticals Ltd (Cycle) is verheugd aan te kondigen dat het een overeenkomst heeft getekend met Catalent, Inc. (Catalent) (NYSE: CTLT), voor
Catalent says the $200 million it will spend over three years to expand drug substance manufacturing capacity and drug product fill/finish capacity in Bloomington, IN, and Madison, WI, reflects a commitment to expand further its fast-growing biologics business.
Our advanced development formulation expertise and innovative topical technologies are ideal for skin, bath & body, hair, fine fragrance and color cosmetics.
El fundador de SpaceX, Elon Musk, observa en una conferencia de prensa posterior al lanzamiento después de que el cohete SpaceX Falcon ...
We can add another commercialized medical device to the company's large product lineup.
Contract drug manufacturer Catalent Inc (CTLT.N) on Friday warned that slow production at three of its facilities will impact its fiscal 2023 results and said… #catalentinc #cfo #thomascastellano #harmans #maryland #catalent #bloomington #indiana #belgium #modernainc
Our advanced development formulation expertise and innovative topical technologies are ideal for skin, bath & body, hair, fine fragrance and color cosmetics.
Our advanced development formulation expertise and innovative topical technologies are ideal for skin, bath & body, hair, fine fragrance and color cosmetics.
The biopharmaceutical analytical testing services market is poised to grow by USD 1.18 billion during 2020-2024, progressing at a CAGR of over 9%.
The S&P 500 Index Committee added Etsy, Teradyne and Catalent to the index, but stopped short of including Tesla.
Catalent offers an array of small molecule analytical capabilities providing a wide range of benefits to help ensure your project success.
✅ The Exact Catalent Color Codes ✅ Hex, CMYK, RGB, Pantone ✅ Meticulously researched ✅ THE Authority on Brand Color Codes & Schemes
Catalent, Inc. (NYSE:CTLT), the leading global diversified provider of advanced delivery technologies and development solutions for drugs, biologics a
Points clés à retenir Les actions de Catalent ont bondi sur les commentaires positifs concernant son activité. La société a
stock sank Thursday after sales of weight-loss blockbuster, Wegovy, nearly doubled year over year, but missed even more bullish expectations. Wegovy generated… #wegovy #danish #novonordisk #novoholdings #catalent #ctlt #wegovyandozempic #glp1 #marketsurge #novo
Catalent will pursue strategic acquisitions and licensing in 2016, said VP Marketing & Strategy Elliott Berger, noting growth areas include complex delivery technologies and specialised logistics.
27-Sep-2018 The partnership will tackle the first-ever formulations of APIs containing up to nine cannabinoids and terpenoids for the treatment of Parkinson’s disease GB Sciences and Catalent Pharma Solutions, a provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has announced that GB Sciences has selected Catalent to provide oral delivery systems, formulation development and clinical-scale oral dose manufacturing of GB Sciences’ proprietary APIs for its Parkinson’s disease therapies. A proof of concept study will be conducted by Catalent at its Swindon, UK facility to evaluate GB Sciences’ clinical candidates GBS101, GBS102 and GBS103 using Catalent’s proprietary Zydis Orally Disintegrating Tablet (ODT) technology. GB Sciences’ three patent-pending APIs for Parkinson’s disease are complex mixtures containing up to nine individual components that function synergistically. Preclinical studies have shown that these cannabinoid-containing complex mixtures are more potent than would have been predicted by combining the activity of each individual compound. “To prepare our Parkinson’s disease formulations for human clinical trials, we wanted the ease-of-use offered by Zydis ODTs for our Parkinson’s patients, many of whom may have difficulties in swallowing. Catalent’s proprietary delivery method also potentially offers consistent dosing for our complex cannabinoid and terpenoid-containing APIs,” explained Dr Andrea Small-Howard, Chief Science Officer of GB Sciences. “The creation of GB Sciences’ proprietary APIs in Zydis ODT formulations is a very important step towards readying them for our Exploratory IND filing and planned phase zero human trial for patients with mild to moderate Parkinson’s disease.” Jonathan Arnold, President of Oral Drug Delivery at Catalent, added: “Dissolving rapidly in the mouth, ODTs are convenient and ease administration, offering an alternate dosage form for patients who have difficulty swallowing, as is sometimes the case with Parkinson’s disease, as well as with geriatric or pediatric patients.” GB Sciences selected Catalent as its development partner due to its expertise in tackling formulation challenges, and ability to achieve the stability and dosing necessary for these novel complex mixtures. Catalent has early development and oral drug delivery solutions available for the efficient delivery of GB Sciences’ proprietary APIs. https://www.manufacturingchemist.com/news/article_page/Catalent_selected_to_provide_oral_delivery_systems_for_GB_Sciences/147512
To be successful, new treatments require real-world outcomes for you, your stakeholders, and most importantly the patients.
Our advanced development formulation expertise and innovative topical technologies are ideal for skin, bath & body, hair, fine fragrance and color cosmetics.
Our advanced development formulation expertise and innovative topical technologies are ideal for skin, bath & body, hair, fine fragrance and color cosmetics.
Tesla-Chef Elon Musk war auf Deutschlandbesuch, als die Nachricht die Runde machte. Auch während des Wochenendes ging vielerorts die Arbeit in der Digitalszene weiter. Die Top-Themen: Tesla muss einen Rückschlag verkraften: Der US-Elektroautobauer wird doch nicht in den S&P-500-Index aufgenommen, obwohl er die Voraussetzungen – vier Quartale im Plus hintereinander – eigentlich erfüllt hat. Statt Tesla […]
Full production at Catalent’s Beinheim softgel plant has begun five months after the discovery of out-of-place capsules led to French regulators suspending operations.
